Piramal Enterprises Ltd


BSE: 500302 | NSE: PEL | ISIN: INE140A01024 
Market Cap: [Rs.Cr.] 9,973 | Face Value: [Rs.] 2
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

 Discuss this stock

Board Meet

03-May-13 
Piramal Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 03, 2013, to consider and approve the Audited Financial Results (Consolidated and Standalone) of the Company for the Financial Year ended March 31, 2013 and also consider recommendation of dividend on the equity shares of the Company for the financial year ended March 31, 2013. Piramal Enterprises Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 03, 2013, inter alia, has recommended a dividend of Rs. 17.5 (Rupees Seventeen and Paise Fifty only) per equity share of face value of Rs. 2/- (i.e. @ 875%) for the financial year ended March 31, 2013 subject to the approval of the shareholders at the ensuing Annual General Meeting ('AGM') of the Company. (As per BSE Announcement Dated on 03.05.2013) 
01-Apr-13 
The Board of Directors of the Company at its meeting held on April 01,2013,has appointed following as Directors of the Company: 1. Mr.Siddharth Mehta - Non-Executive Independent Director 2. Mr.Gautam Banerjee - Non-Executive Director 
11-Feb-13 
Piramal Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 11, 2013, to consider and take on record the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and nine months ended December 31, 2012, which would be subjected to Limited Review by the Auditors of the Company (Q3). 
05-Nov-12 
Piramal Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 05, 2012, to consider and take on record the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter and half year ended September 30, 2012 (Q2). The results shall be subject to limited review. Piramal Enterprises Ltd has informed BSE regarding Outcome of Board Meeting held on November 05, 2012. (As per BSE Announcement Dated on 05.11.2012) The Board of Directors of the Company at its meeting held on November 05,2012,inter alia,has considered and approved the Scheme of Amalgamation and Arrangement between PHL Holdings Private Limited ('PHPL') and Piramal Enterprises Limited ('the Company') and their respective shareholders ('the Scheme') under Sections 391 to 394 read with Sections 100 to 103 and other applicable provisions of the Companies Act,1956. PHPL is a company forming part of the Promoter Group and currently holds 8,40,92,879 Equity Shares of the Company which constitutes 48.73% of the equity shareholding of the Company.The main purpose of the Scheme is to facilitate a more efficient holding structure by the Promoter Group. Pursuant to the merger,the equity shares held by PHPL in the Company shall stand cancelled, and equivalent number of equity shares of the Company will be issued to the equity shareholders of PHPL. There would be no impact on the financials and the shareholding pattern of the Company as a result of the merger.The promoters as well as the public will continue to hold the same percentage of equity shares in the Company,post merger.The entire cost of the Scheme would be borne by the promoters and / or PHPL and the promoters will keep the Company indemnified against any liability,if any,arising as a result of this merger. The Scheme is subject to requisite consents and approval of the requisite majority of the shareholders,lenders and creditors of the companies,the Hon'ble High Court of Judicature at Bombay and any other statutory or regulatory authorities, which by law may be necessary for the implementation of the Scheme. (As Per Bulletin Dated on 05.11.2012) 
14-Aug-12 
Piramal Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 14, 2012 to consider and take on record the Unaudited Financial Results (consolidated and standalone) of the Company for the 1st Quarter ended June 30, 2012. The results shall be subjected to limited review. 

AGM

25-Jul-13
AGM : 25.07.2013 
19-Jul-12
Piramal Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 11, 2012 to July 19, 2012 (both days inclusive) for the purpose of Payment of Dividend & 65th Annual General Meeting (AGM) of the Company to be held on July 19, 2012. The dividend on Equity Shares, if declared by the Members at the AGM, will be paid between July 20, 2012 and July 25, 2012. Piramal Healthcare Ltd has informed BSE that 65th Annual General Meeting of the Company will be held on July 19, 2012. (As Per BSE ANnouncement Website Dated on 25/06/2012) Piramal Healthcare Ltd has informed BSE that the 65th Annual General Meeting of the Shareholders of the Company was held on July 29, 2012, under Clause 35A. (As Per BSE Anouncement Website Dated on 20/07/2012) 
09-Aug-11
Piramal Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 01, 2011 to August 09, 2011 (both days inclusive) for the purpose of Payment of Dividend & 64th Annual General Meeting (AGM) of the Company to be held on August 09, 2011. Piramal Healthcare Ltd has informed BSE that at the 64th Annual General Meeting of the Company which was held on August 09, 2011, all the businesses mentioned in the Notice convening the said meeting were transacted and all the resolutions were passed unanimously. A brief summary of the business transacted at the AGM is furnished below: - The Audited Accounts for the year ended March 31, 2011 were adopted; - Dividend at Rs. 12/- per equity share of Rs. 2/- (i.e. @ 600%) on 16,72,10,515 Equity Shares was declared for the financial year ended March 31, 2011; - Mr. Y. H. Malegam and Mr. Deepak Satwlekar have been reappointed as Directors of the Company; - M/s. Price Waterhouse, Chartered Accountants, Mumbai have been reappointed as Auditors of the Company; - Mr. Amit Chandra has bee appointed as Director of the Company. (As Per BSE Announcement Dated on 16.08.2011) 
09-Jul-10
Piramal Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 01, 2010 to July 09, 2010 (both days inclusive) for the purpose of 63rd Annual General Meeting (AGM) of the Company to be held on July 09, 2010. Piramal Healthcare Limited has submitted to the Exchange a brief summary of the business transacted at the AGM held on July 09, 2010: 1)The Audited Accounts for the year ended March 31, 2010 were adopted; 2)Dividend at Rs. 5.40 per equity share of Rs.2/- (i.e. @ 270%) on 20,90,13,144 Equity Shares was declared for the financial year ended March 31, 2010; 3) Mr. R. A. Shah and Mr. N. Vaghul have been reappointed as Directors of the Company; 4) M/s. Price Waterhouse, Chartered Accountants, Mumbai have been reappointed as Auditors of the Company. Special Business: a) Special Resolution for payment of commission to Non-Executive Directors at the rate upto 1 percent of the net profits of the Company in each year for a further period of 5 years commencing from the Company's financial year ending March 31, 2011 was duly passed; b)Special Resolution for re-appointment of Mr. N. Santhanam as Executive Director & Chief Operating Officer, not liable to retire by rotation, for a period of 3 years with effect from October 25, 2010 was duly passed; c) Special Resolution for keeping of register and index of members and debenture-holders with the Company's Share Transfer Agents for the time being, who presently are Link Intime India Private Limited having their office at C-13, Pannalal Silk Mills Compound LBS Marg, Bhandup (West), Mumbai - 400 078 was duly passed. (As Per NSE Bulletin dated on 15.07.2010) 
18-Jun-09
Piramal Healthcare Ltd has informed BSE that the 62nd Annual General Meeting (AGM) of the Company to be held on June 18, 2009. Piramal Healthcare Ltd has informed BSE that the members at the 62nd Annual General Meeting (AGM) of the Company held on June 18, 2009, inter alia, have passed the following resolutions: 1. The Audited Accounts for the year ended March 31, 2009 were adopted. 2. Dividend at Rs 4.20 per equity share on 20,90,13,144 Equity Shares of Rs 2/- each (i.e. @ 210%) was declared for the financial year ended March 31, 2009. 3. Mr. Keki Dadiseth and Mr. S Ramadorai have been reappointed as Directors of the Company. 4. M/s. Price Waterhouse, Chartered Accountants, Mumbai have been reappointed as Auditors of the Company. 5. Special Resolution for appointment of Ms. Nandini Piramal as Executive Director and related resolution for increasing the strength of the Board from 9 to 10 (which is within the maximum limit of 20 fixed by the Articles). 6. Special Resolution for keeping of register and index of members and debenture-holders at the Company's Share Transfer Agents, Freedom Registry Ltd (formerly known as M/s. Amtrac Management services Ltd) at their administrative office, which is presently at 8, Peninsula Centre, Dr. S S Rao Road, Parel, Mumbai-400 012 and which is proposed to be shifted to Unit No. 129, Bayside Mall. 35/C, M. Malvia Marg, Tardeo Road, Haji All, Mumbai 400 034; 7. Ordinary Resolution u/s. 293 (1) (d) for increasing Borrowing Powers to Rs 1500 Crores over and above the paid up share capital and free reserves. 8. Ordinary Resolution u/s. 293 (1) (a) for mortgage / charge that may have to be created on the borrowings availed pursuant to the aforesaid resolution u/s. 293 (1) (d). (As Per BSE Announcement Website dated on 22.06.2009) 

EGM

13-Mar-13
Piramal Enterprises Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on March 13, 2013. Piramal Enterprises Ltd has informed BSE that pursuant by an Order made on February 01, 2013, in the above Company Summons for Direction, the Hon'ble High Court of Judicature at Bombay has directed that a meeting of the Equity Shareholders of the Company, be convened and held at Y. B. Chavan Auditorium, General Jagannath Bhosale Marg, Opposite Mantralaya, Nariman Point, Mumbai - 400 021, Maharashtra on March 13, 2013 at 11:00 a.m., for the purpose of considering and if thought fit, approving with or without modification(s), the proposed arrangement embodied in the Scheme of Amalgamation and Arrangement between PHL Holdings Private Limited and Piramal Enterprises Limited and their respective shareholders and creditors (¶he Scheme'). Piramal Enterprises Ltd has informed BSE regarding Outcome of Court Convened Meeting and Extraordinary General Meeting of the Shareholders of the Company held on March 13, 2013, pursuant to clause 35A. (As per BSE Announcement Dated on 15.03.2013) 
09-Aug-11
Piramal Healthcare Ltd has informed BSE that The Court Convened Meeting for approval of the Scheme of Arrangement for demerger of the NCE Research Unit of Piramal Life Sciences Limited ('PLSL') into the Company ('the Scheme') was duly held on August 09, 2011 and the shareholders have approved the Scheme by an overwhelming requisite majority. Piramal Healthcare Ltd has informed BSE that the shareholders at the Extra Ordinary General Meeting (EGM) of the Company held on August 09, 2011, inter alia, has approved all the business mentioned in the Notice convening the EGM by an overwhelming requisite majority. (As Per BSE Announcement Dated on 16.08.2011) 
23-Nov-07
Nicholas Piramal India Ltd pursuant to the order made by the Hon'ble High Court of Judicature at Bombay, a meeting of the Equity Shareholders of the Company will be held on November 23, 2007, for the purpose of considering and if thought fit, approving, with or without modification, the arrangements embodied in the Composite Scheme of Arrangement ("the Scheme") between the Company and NPIL Research and Development Ltd. Further the Company has informed BSE that pursuant to the order made by the Hon'ble High Court of Judicature at Bombay, a meeting of the Shareholders of the 5%- 2,33,72,280 Cumulative Redeemable Preference Shares of Rs 10 each (""the Series II Preference Shareholders") of the Company will be held on November 23, 2007, or soon after the conclusion of the meeting of the Equity Shareholders which has been convened on the same date by the Hon'ble High Court of Judicature at Bombay vide its aforesaid Order, whichever is later, for the purpose of considering and if thought fit, approving, with or without modification, the arrangements embodied in the Composite Scheme of Arrangement ("the Scheme") between the Company and NPIL Research & Development Ltd. Nicholas Piramal India Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the members of the Company will be held on November 23, 2007, inter alia, to transact the following business: 1. Reduction in the paid up value of the equity shares of the Company from Re 2 per equity share to Rs 1.90 per equity share, aggregating to a total reduction of Rs 2,09,01,314 in the Equity Share Capital of the Company ("Equity Capital Reduction"), in the manner as provided in Clause 6 of the Composite Scheme of Arrangement between the Company and NPIL Research and Development Ltd ("Scheme") which is subject to sanction by the Hon'ble High Court, subject to necessary provisions & approvals. 2. Reduction in the face value of the 5% Cumulative Redeemable Preference Shares of Rs 100 each ("Series I Preference Shares") of the Company from Rs 100 per share to Rs 90 per share ("Series I Preference Share Value Reduction"), in the manner as provided in Clause 5.2.3 of the Composite Scheme of Arrangement ("Scheme") between the Company and NPIL Research and Development Ltd ("NRDL") which is subject to sanction by the Hon'ble High Court, which reduction may take place in the event of the issue of Preference Shares by NRDL to the holders of the Series I Preference Shares of the Company under Clause 5.2.1 of the Scheme, subject to necessary provisions & approvals. 3. Reduction in the face value of the 5% Cumulative Redeemable Preference Shares of Rs 10 each ("Series II Preference Shares") of the Company from Rs 10 per share to Rs 9 per share ("Series II Preference Share Value Reduction"), in the manner as provided in Clause 5.2.3 of the Composite Scheme of Arrangement ("Scheme") between the Company and NPIL Research and Development Ltd ("NRDL") which is subject to sanction by the Hon'ble High Court, which reduction may take place in the event of the issue of Preference Shares by NRDL to the holders of the Series II Preference Shares of the Company under Clause 5.2.1 of the Scheme; subject to necessary provisions & approvals. 4. In the event of allotment of Preference Shares by NRDL being made to the holders of the 15,00,000 - 5% Cumulative Redeemable Preference Shares of Rs 100 each ("Series I Preference Shares") and the holders of the 2,33,72,280 - 5% Cumulative Redeemable Preference Shares of Rs 10 each ("Series II Preference Shares") of the Company under clause 5.2.1 of the Composite Scheme of Arrangement ("Scheme") between the Company and NPIL Research and Development Ltd, resulting in the reduction in the face value of the Series I Preference Shares from Rs 100 per share to Rs 90 per share and in the face value of the Series II Preference Shares from Rs 10 per share to Rs 9 per share as contemplated under clause 5.2.3 of the Scheme, the Authorised Share Capital of the Company shall be consequently altered and the existing Clause 'V' (being Capital Clause) of the Memorandum of Association of the Company shall be substitued by the following Clause: "Clause V The Authorised Share Capital of the Company is Rs 121,16,27,720 (Rupees One hundred twenty one crores, sixteen lakhs, twenty seven thousand, seven hundred and twenty only) divided into 25,00,00,000 Equity Shares of Rs 2/- each, 15,00,000 Preference Shares of Rs 90/- each, 15,00,000 Preference Shares of Rs 100/- each, 2,33,72,280 Preference Shares of Rs 9/- each, 6,27,720 Preference Shares of Rs 10/- each and 10,50,00,000 Unclassified Shares of Rs 2/- each. Subject to the provisions of the Companies Act, 1956 ('the Act') the Board shall have power to increase or reduce the Authorised Share Capital, to classify the unclassified shares, to re-classify the classified shares, and to divide the shares so classified or re-classified in shares of several classes permissible under the Act and to attach thereto respectively such preferential, deferred, qualified and other special rights, privileges, restrictions and conditions as may be determined under the provisions of the law in force for the time being and the regulations of the Company and to vary, modify, abrogate or deal with any such rights, privileges, restrictions and conditions in the manner prescribed by the regulations of the Company and under the provisions of the law in force". Further, to alter the Article 3 of the Articles of Association of the Company by substituting the following Article in place and in lieu thereof: "Article 3 The Authorised Share Capital of the Company is Rs 121,16,27,720 (Rupees One hundred twenty one crores, sixteen lakhs, twenty seven thousand, seven hundred and twenty only) divided into 25,00,00,000 Equity Shares of Rs 2/- each, 15,00,000 Preference Shares of Rs 90/- each, 15,00,000 PreferenceShares of Rs 100/-each, 2,33,72,280 Preference Shares of Rs 9/- each, 6,27,720 Preference Shares of Rs 10/- each and 10,50,00,000 Unclassified Shares of Rs 2/- each." 5. Subject to the sanction of the Composite Scheme of Arrangement ("Scheme") between the Company and NPIL Research and Development Ltd ("NRDL") by the Hon'ble High Court of Judicature at Bombay, consent of the Company be and is hereby accorded for debiting the Securities Premium Account in the books of account of the Company pursuant to Clause 7.22 of the Scheme, the excess of book values of assets over liabilities of the Company transferred to NRDL under the Scheme, after adjusting the reduction in equity share capital referred to in clause 6.1 of the Scheme to the extent of Rs 2,09,01,314 and after giving effect to Clause 4.1.5 of the Scheme, subject to necessary provisions & approvals. 6. Re-appointment of Dr. (Mrs.) Swati A Piramal ("Dr. Piramal") as Director in Whole-time employment of the Company (designated as 'Director - Strategic Alliances & Communication'), not liable to retire by rotation, for a further period of five years with effect from November 20, 2007, on remuneration, terms & conditions. 7. Appointment of Mr. N Santhanam as a Director of the Company. 8. Appointment of Mr. N Santhanam as Director in whole-time employment of the Company (designated as "Executive Director & Chief Financial Officer") for a period of 3 years with effect from October 25, 2007, not liable retire by rotation, on remuneration, terms & conditions. Nicholas Piramal India Ltd pursuant to the meeting of the Equity Shareholders and Series II Preference Shareholders of the Company at its court convened meeting held on November 23, 2007, have approved the Composite Scheme of Arrangement between the Company and NPIL Research & Development Ltd, by overwhelming requisite majority. (As Per BSE Announcement Website Dated on 29/11/2007) Nicholas Piramal India Ltd has informed BSE that the Extraordinary General Meeting (EGM) of the Company held on November 23, 2007, inter alia, all the resolutions for the businesses mentioned in the Notices convening the said Meetings were duly passed. The summary of the businesses transacted at the said Meetings are given below: A. Business Transacted at the Extraordinary General Meeting of the Equity and Preference Shareholders - Reduction of Equity Share Capital from Rs 2 per share to Rs 1.90 per share and simultaneous capitalization of equivalent amount from General Reserves, consequent to which, the paid-up value of the Equity Shares would be retained at Rs 2 per share; - Reduction of Preference Share Capital [Series I] from Rs 100 per share to Rs 90 per share, in the event of NPIL Research & Development Ltd ("NRDL")) allotting its Preference Shares of Rs 10 each to the Series I Preference Shareholders of the Company in the ratio of 1:1, under the Scheme of Arrangement between the Company and NRDL ("the said Scheme"); - Reduction of Preference Share Capital [Series II] from Rs 10 per share to Rs 9 per share, in the event of NRDL allotting its Preference Shares of Rs 10 each to the Series II Preference Shareholders of the Company in the ratio of 1:10, under the said Scheme; - Alteration of the Authorised Preference Share Capital (Series I & II), in the event of the Reduction of the Series I & II Preference Share Capital referred to above taking effect under the said Scheme; - Utilisation of Securities Premium Account pursuant to the said Scheme; - Re-appointment of Dr. (Mrs.) Swati A Piramal as Director-Strategic Alliances & Communications for a further period of 5 years w.e.f. November 20, 2007; - Appointment of Mr. N Santhanam as Director; - Appointment of Mr. N Santhanam as Executive Director & Chief Financial Officer for a period of 3 years w.e.f. October 25, 2007; B. Business Transacted at the Extraordinary General Meeting of the Series II Preference Shareholders - Reduction of Preference Share Capital [Series II] from Rs 10 per share to Rs 9 per share; in the event of NRDL allotting its Preference Shares of Rs 10 each to the Series II Preference Shareholders of the Company in the ratio of 1:10, under the said Scheme. (As per BSE Announcement Website dated on 29/11/2007) 
08-Mar-04
The company has informed the following :- 1. The Court Convened Meeting for approval of the Scheme of Amalgamation for the merger of Canere Actives & Fine Chemicals Pvt Ltd and the Company was held on March 8, 2004 and the said Scheme has been approved by the shareholders. 2. The EGM of the shareholders of the Company which was also convened on March 8, 2004 was held immediately after the conclusion of the aforesaid Court Convened Meeting. The following business were approved by the shareholders and the resolutions were passed: (a) Approval to the increase in Authorised Share Capital of the company from Rs. 750 million to Rs. 1250 million, by creation of 2,40,00,000 Preference Shares of Rs. 10/- each, 15,00,000 Preference Shares of Rs. 100/- each and 1,10,00,000 Unclassified shares of Rs 10/- each and to the consequential amendments to the relevant clauses of the Memorandum and Articles of Association of the Company. (b) Approval under the Companies Act, 1956 to the issue and allotment by the Company of: i) 15,00,000 - 5% Cumulative Redeemable Preference Shares of Rs 100 each, credited as fully paid up, to the shareholders of CANERE, in the ration of 3:20 (i.e. 3 Preference Shares for every 20 Equity Shares held in CANERE). ii) 2,33,72,280 - 5% Cumulative Redeemable Shares of Rs 10 each, credited as fully paid up to the shareholders of Morarjee Goculdas Spg & Wvg Co. Ltd (Morarjee) in the ratio of 6:5 (i.e. 6 Preference Shares for every 5 equity shares held in Morarjee). iii) Approval under u/s 100 and 78 of the Act by special resolution, for charging and debiting to the Company's Share Premium Account, the deficit of the aggregate value of assets over the value of liabilities recorded by the Company upon their transfer to and vesting in the Company under the Scheme, after adjusting for the face value of the Preference Shares to be issued and allotted as aforesaid.  
19-Sep-03
EGM 19/09/2003 - Court Convened EGM to approve the Scheme of Arrangement. Nicholas Piramal India Ltd. has informed the Exchange that an EGM will be held on September 19, 2003 for approval of the Scheme of Arrangement between the Company and Kojam Fininvest Limited and their respective Members. (Refer NSE dated 04/09/2003) Nicholas Piramal India Ltd. has informed the Exchange regarding the Court Convened Meeting and Extra-ordinary General Meeting of the Members of the Company held on September 19, 2003. The Scheme of Arrangement ("the Scheme") between the Company and Kojam Fininvest Limited ("KOJAM") was modified by the Company by inclusion of the following clause: "The listing and admission of new equity shares of KFL issued in terms of clause 5.1 of the Scheme of Arrangement on The National Stock Exchange of India Limited, The Stock Exchange, Mumbai and The Stock Exchange, Ahmedabad is not automatic and will be subject to fulfillment of listing criteria of The National Stock Exchange of India Limited, The Stock Exchange, Mumbai and The Stock Exchange, Ahmedabad for such issues and also subject to such other terms and conditions as may be prescribed by The National Stock Exchange of India Limited, The Stock Exchange, Mumbai and The Stock Exchange, Ahmedabad at the time of KFL seeking listing". The same has been approved by the shareholders in its meeting held on September 19, 2003. In the Extra-ordinary General Meeting ("EGM") held immediately after the conclusion of the aforesaid Court Convened Meeting, the Special Resolution for seeking consent of the shareholders u/s 100 and 78 of the Companies Act 1956, for debiting to the Company's Share Premium Account the carrying cost of the Investment in Gujarat Glass Pvt. Ltd. to be transferred to KOJAM under the Modified Scheme, was unanimously approved by the shareholders. (Refer NSE dated 23/09/2003) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds. 100,054.49 69.51 12.34 27.45 26.1 27.0 0.01
Dr Reddy's Labs 34,771.49 27.48 4.57 18.79 14.3 16.6 0.25
Cipla 33,513.05 21.89 4.44 14.11 15.9 19.8 0.03
Wockhardt 19,121.16 113.90 158.92 12.82 237.0 30.3 2.09
Ranbaxy Labs. 18,791.99 0.00 9.78 72.87 0.0 0.0 2.38
Cadila Health. 16,536.85 40.08 6.49 18.45 28.4 24.2 0.40
Glenmark Pharma. 15,530.70 40.23 6.16 23.94 12.7 11.7 0.39
Piramal Enterp. 9,973.39 0.00 0.94 23.66 0.8 2.1 0.07
Ipca Labs. 7,559.38 22.73 5.99 10.09 24.2 23.7 0.49
Torrent Pharma. 6,112.53 11.43 4.69 11.66 29.6 25.5 0.48
Biocon 5,637.00 19.65 2.56 12.20 12.6 13.6 0.08
Aurobindo Pharma 5,534.26 13.16 2.22 22.89 10.7 8.8 1.01
Strides Arcolab 5,243.64 35.75 3.82 16.20 5.1 5.7 0.97
Mylan Lab. 3,273.19 6.80 1.77 0.00 26.9 26.1 0.59
Alembic Pharma 2,455.21 15.60 5.34 5.60 39.5 27.7 1.07

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

Ajay G Piramal , Chairman  

Keki Dadiseth , Director  

Swati A Piramal , Vice Chairperson  

Nandini Piramal , Executive Director  


Company Head Office / Quarters:
Piramal Tower,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013
Phone : 91-22-30466666
Fax : 91-22-24902363
E-mail : complianceofficer.phl@piramal.com
Web : http://www.piramalhealthcare.com
Registrars:
Link Intime India Pvt Ltd
C-13 Pannalal Silk
Mills Cmpd LBS Marg
Bhandup West
Mumbai - 400 078

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Opening : Just Dial
listIssue Open : Onesource Techm.
Economic Events
list Rightmove House Prices (YoY)
list Fed's Evans Speaks on Economy in Chicago
Results
list India Cements | Voltas | Apollo Hospitals | Future Retail